Urine-compatible polymer for long-term ureteral stenting.
Internal double-J ureteral stents were designed from a urine-compatible polymer (C-Flex), and 35 stents were placed in patients. The overall patency rate for the stents was 80%, with most stent failures occurring before 2 months; the follow-up period ranged from 2 to 16 months, with a mean follow-up for all stents of 5.0 months. Stents were considered patent at last follow-up only if they had been in place for at least 2 months. No migration or fracture of the stents occurred. Physical properties of urine-exposed stents were compared with those of virgin tubing and tubing exposed for 1 year to shelf conditions. Stent patency was optimized by increasing urine flow by increasing the patient's voluntary oral intake, administering prophylactic oral antibiotics, and avoiding placement of stents into grossly bloody or infected collecting systems.
D000328:Adult; D000368:Aged; D001672:Biocompatible Materials; D004868:Equipment Failure; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011095:Polyethylenes / Q000627:therapeutic use*; D011137:Polystyrenes / Q000627:therapeutic use*; D014546:Urinary Catheterization
D001672:Biocompatible Materials; D011095:Polyethylenes; D011137:Polystyrenes; C050192:styrene-ethylene-butylene-styrene-block copolymer